$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 12.66% on an annualized basis producing an average annual return of 24.59%. Currently, Regeneron Pharmaceuticals has a market capitalization of $77.22 billion.

Buying $100 In REGN: If an investor had bought $100 of REGN stock 15 years ago, it would be worth $2,688.18 today based on a price of $702.69 for REGN at the time of writing.

Regeneron Pharmaceuticals’s Performance Over Last 15 Years

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.